Little Leo Pharma enters the prize-fight ring with positive PhIII atopic dermatitis data. Now they just have to beat Dupixent
A day after new Sanofi CEO Paul Hudson staked his reputation and the future of the pharma giant on making Dupixent a megasuccess story …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.